Sulfoximines as kinase inhibitors
US8558002B2 · kind B2 · utility
1Cited by
1References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2011 |
| Grant date | Oct 15, 2013 |
| Priority date | — |
| Expiry date | Oct 20, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.